1,302
Views
8
CrossRef citations to date
0
Altmetric
Pharmacological Aspects

Current perspectives in the management of treatment-resistant depression

Perspectivas actuales en el manejo de la depresión resistente al tratamiento

Perspectives actuelles dans la prise en charge de la dépression résistant au traitement

&
Pages 53-60 | Published online: 01 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Dominic Pilon, Swapna Karkare, Maryia Zhdanava, John J. Sheehan, Aurélie Côté-Sergent, Aditi Shah, Oliver J. Lopena, Patrick Lefebvre, Kruti Joshi & Leslie Citrome. (2021) Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy. Journal of Medical Economics 24:1, pages 1299-1308.
Read now
Yi-Chien Hsu, Yu-Ching Chou, Hsin-An Chang, Yu-Chen Kao, San-Yuan Huang & Nian-Sheng Tzeng. (2015) Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study. Neuropsychiatric Disease and Treatment 11, pages 225-232.
Read now
Khalid Saad Al-Harbi. (2012) Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Preference and Adherence 6, pages 369-388.
Read now

Articles from other publishers (5)

Mehedi Hasan Bappi, Abdullah Al Shamsh Prottay, Hossam Kamli, Fatema Akter Sonia, Md. Nayem Mia, Md. Showkoth Akbor, Md. Munnaf Hossen, Samir Awadallah, Mohammad S. Mubarak & Muhammad Torequl Islam. (2023) Quercetin Antagonizes the Sedative Effects of Linalool, Possibly through the GABAergic Interaction Pathway. Molecules 28:14, pages 5616.
Crossref
Maryia Zhdanava, Swapna Karkare, Dominic Pilon, Kruti Joshi, Carmine Rossi, Laura Morrison, John Sheehan, Patrick Lefebvre, Oliver Lopena & Leslie Citrome. (2021) Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug–Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression. Advances in Therapy 38:9, pages 4900-4916.
Crossref
Maryia ZhdanavaHarsh KuvadiaKruti JoshiElla DalyDominic PilonCarmine RossiLaura MorrisonPatrick LefebvreCraig Nelson. (2020) Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions. Journal of Managed Care & Specialty Pharmacy 26:8, pages 996-1007.
Crossref
Jin-Won Kim & Koo-Won Lim. (2019) Analysis of Multivariate Latent Growth Model of Social Activity, Health Status, and Depression in the Elderly. Korean Journal of Lesure, Recreation & Park 43:4, pages 1-15.
Crossref
Prasad Shetty. (2016) Pharmacogenomics and its Future Implications in Treatment-resistant Depression. Indian Journal of Private Psychiatry 13:2, pages 71-76.
Crossref